Price $265.07 |
Market Cap
14.01B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
87.1
|
P/B
12.38
|
P/S
17.09
|
Dividend %
-
|
|
P/CF
121.5
|
P/FCF
57.6
|
Op. Cash Flow
282.1K
|
FCF
5.2
|
|
Op. Margin
27.30%
|
Net Margin
19.90%
|
ROE
15.10%
|
ROI
17.90%
|
|
ROA
13.30%
|
EPS Growth
-38.50%
|
Current Ratio
4.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $3.26 | - | - | 641.2M | Strong Buy |
| International Stem Cell Corp (ISCO) | $0.55 | - | - | 4.7M | Strong Buy |
| Aerpio Pharmaceuticals Inc (ARPO) | $1.50 | - | - | 58.1M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.94 | - | - | 70.1M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $0.24 | - | - | 19.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
